Dmytriw, Adam AGhozy, SheriefSalim, Hamza AdelMusmar, BaselSiegler, James EKobeissi, HassanShaikh, HamzaKhalife, JaneAbdalkader, MohamadKlein, PiersNguyen, Thanh NHeit, Jeremy JRegenhardt, Robert WCancelliere, Nicole MEl Naamani, KareemAmllay, AbdelazizMeyer, LukasDusart, AnneBellante, FlavioForestier, GéraudRouchaud, AymericSaleme, SuzanaMounayer, CharbelFiehler, JensKühn, Anna LuisaPuri, Ajit SDyzmann, ChristianKan, Peter TColasurdo, MarcoMarnat, GaultierBerge, JérômeBarreau, XavierSibon, IgorNedelcu, SimonaHenninger, NilsMarotta, Thomas RStapleton, Christopher JRabinov, James DOta, TakahiroDofuku, ShogoYeo, Leonard L LTan, Benjamin Y QMartinez-Gutierrez, Juan CarlosSalazar-Marioni, SergioSheth, SunilRenieri, LeonardoCapirossi, CarolinaMowla, AshkanAdeeb, NimerCuellar-Saenz, Hugo HTjoumakaris, Stavropoula IJabbour, PascalKhandelwal, PriyankBiswas, ArundhatiClarençon, FrédéricElhorany, MahmoudPremat, KevinValente, IacopoPedicelli, AlessandroFilipe, João PedroVarela, RicardoQuintero-Consuegra, MiguelGonzalez, Nestor RMöhlenbruch, Markus AJesser, JessicaCostalat, VincentTer Schiphorst, AdrienYedavalli, VivekHarker, PabloChervak, Lina MAziz, YasminGory, BenjaminStracke, Christian PaulHecker, ConstantinKadirvel, RamanathanKiller-Oberpfalzer, MonikaGriessenauer, Christoph JThomas, Ajith JHsieh, Cheng-YangLiebeskind, David SRadu, Răzvan AlexandruAlexandre, Andrea MTancredi, IllarioFaizy, Tobias DFahed, RobertWeyland, Charlotte SLubicz, BorisPatel, Aman BPereira, Vitor MendesGuenego, Adrien2024-09-192024-09-192024-08-06Dmytriw AA, Ghozy S, Salim HA, Musmar B, Siegler JE, Kobeissi H, Shaikh H, Khalife J, Abdalkader M, Klein P, Nguyen TN, Heit JJ, Regenhardt RW, Cancelliere NM, El Naamani K, Amllay A, Meyer L, Dusart A, Bellante F, Forestier G, Rouchaud A, Saleme S, Mounayer C, Fiehler J, Kühn AL, Puri AS, Dyzmann C, Kan PT, Colasurdo M, Marnat G, Berge J, Barreau X, Sibon I, Nedelcu S, Henninger N, Marotta TR, Stapleton CJ, Rabinov JD, Ota T, Dofuku S, Yeo LLL, Tan BYQ, Martinez-Gutierrez JC, Salazar-Marioni S, Sheth S, Renieri L, Capirossi C, Mowla A, Adeeb N, Cuellar-Saenz HH, Tjoumakaris SI, Jabbour P, Khandelwal P, Biswas A, Clarençon F, Elhorany M, Premat K, Valente I, Pedicelli A, Filipe JP, Varela R, Quintero-Consuegra M, Gonzalez NR, Möhlenbruch MA, Jesser J, Costalat V, Ter Schiphorst A, Yedavalli V, Harker P, Chervak LM, Aziz Y, Gory B, Stracke CP, Hecker C, Kadirvel R, Killer-Oberpfalzer M, Griessenauer CJ, Thomas AJ, Hsieh CY, Liebeskind DS, Radu RA, Alexandre AM, Tancredi I, Faizy TD, Fahed R, Weyland CS, Lubicz B, Patel AB, Pereira VM, Guenego A; MAD-MT Consortium. Assessment of Thrombectomy versus Combined Thrombolysis and Thrombectomy in Patients with Acute Ischemic Stroke and Medium Vessel Occlusion. Radiology. 2024 Aug;312(2):e233041. doi: 10.1148/radiol.233041. PMID: 39105645; PMCID: PMC11366672.1527-131510.1148/radiol.23304139105645https://hdl.handle.net/20.500.14038/53804Background The combination of intravenous thrombolysis (IVT) with mechanical thrombectomy (MT) may have clinical benefits for patients with medium vessel occlusion. Purpose To examine whether MT combined with IVT is associated with different outcomes than MT alone in patients with acute ischemic stroke (AIS) and medium vessel occlusion. Materials and Methods This retrospective study included consecutive adult patients with AIS and medium vessel occlusion treated with MT or MT with IVT at 37 academic centers in North America, Asia, and Europe. Data were collected from September 2017 to July 2021. Propensity score matching was performed to reduce confounding. Univariable and multivariable logistic regression analyses were performed to test the association between the addition of IVT treatment and different functional and safety outcomes. Results After propensity score matching, 670 patients (median age, 75 years [IQR, 64-82 years]; 356 female) were included in the analysis; 335 underwent MT alone and 335 underwent MT with IVT. Median onset to puncture (350 vs 210 minutes, P < .001) and onset to recanalization (397 vs 273 minutes, P < .001) times were higher in the MT group than the MT with IVT group, respectively. In the univariable regression analysis, the addition of IVT was associated with higher odds of a modified Rankin Scale (mRS) score 0-2 (odds ratio [OR], 1.44; 95% CI: 1.06, 1.96; P = .019); however, this association was not observed in the multivariable analysis (OR, 1.37; 95% CI: 0.99, 1.89; P = .054). In the multivariable analysis, the addition of IVT also showed no evidence of an association with the odds of first-pass effect (OR, 1.27; 95% CI: 0.9, 1.79; P = .17), Thrombolysis in Cerebral Infarction grades 2b-3 (OR, 1.64; 95% CI: 0.99, 2.73; P = .055), mRS scores 0-1 (OR, 1.27; 95% CI: 0.91, 1.76; P = .16), mortality (OR, 0.78; 95% CI: 0.49, 1.24; P = .29), or intracranial hemorrhage (OR, 1.25; 95% CI: 0.88, 1.76; P = .21). Conclusion Adjunctive IVT may not provide benefit to MT in patients with AIS caused by distal and medium vessel occlusion. © RSNA, 2024 Supplemental material is available for this article. See also the editorial by Wojak in this issue.enAssessment of Thrombectomy versus Combined Thrombolysis and Thrombectomy in Patients with Acute Ischemic Stroke and Medium Vessel OcclusionJournal ArticleRadiology